Skip to main content
Erschienen in: Pituitary 3/2021

16.11.2020

Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma

verfasst von: Hyongmin Oh, Hyeon Cheun, Yoon Jung Kim, Hyun-Kyu Yoon, Ho Kang, Hyung-Chul Lee, Hee-Pyoung Park, Jung Hee Kim, Yong Hwy Kim

Erschienen in: Pituitary | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Diabetes insipidus (DI) develops commonly after endoscopic transsphenoidal surgery (ETS). We retrospectively investigated the incidence, onset, duration and predictors of DI after ETS in patients with non-functioning pituitary adenoma (NFPA).

Methods

A total of 168 patients who underwent ETS to remove NFPAs were included. Various perioperative data on demographics, comorbidities, previous treatments, perioperative hormone deficiencies, tumor characteristics, surgery, anesthesia, intraoperative fluid balance, perioperative laboratory findings, postoperative complications, readmission and hospital length of stay were collected and analyzed. Patients were diagnosed with DI and treated with desmopressin when they showed urine output > 5 mL/kg/hr with a serum sodium concentration > 145 mmol/L or an increase ≥ 3 mmol/L in serum sodium concentration between two consecutive tests after surgery. DI was considered permanent when desmopressin was prescribed for > 6 months after surgery.

Results

Seventy-seven (45.8%) patients experienced postoperative DI and 10 (6.0%) patients suffered from permanent DI. The median onset of DI and the median duration of transient DI were postoperative day 1 and 5 days, respectively. In multivariable logistic regression analysis, cephalocaudal tumor diameter (odds ratio [95% confidence interval] 2.59 [1.05–6.36], P = 0.038) was related to postoperative DI. In receiver operating characteristic analysis, its area under the curve was 0.68 (95% confidence interval 0.59–0.76, P < 0.001). Its optimal cutoff value that maximized the sum of sensitivity and specificity for postoperative DI was 2.7 cm.

Conclusions

Postoperative DI was observed in 45.8% of patients undergoing ETS to remove NFPAs. A large cephalocaudal tumor diameter was predictive of postoperative DI in such patients.
Literatur
1.
Zurück zum Zitat Lobatto DJ, de Vries F, Zamanipoor Najafabadi AH, Pereira AM, Peul WC, Vliet Vlieland TPM, Biermasz NR, van Furth WR (2018) Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: a systematic review. Pituitary 21:84–97CrossRef Lobatto DJ, de Vries F, Zamanipoor Najafabadi AH, Pereira AM, Peul WC, Vliet Vlieland TPM, Biermasz NR, van Furth WR (2018) Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: a systematic review. Pituitary 21:84–97CrossRef
2.
Zurück zum Zitat Schreckinger M, Szerlip N, Mittal S (2013) Diabetes insipidus following resection of pituitary tumors. Clin Neurol Neurosurg 115:121–126CrossRef Schreckinger M, Szerlip N, Mittal S (2013) Diabetes insipidus following resection of pituitary tumors. Clin Neurol Neurosurg 115:121–126CrossRef
3.
Zurück zum Zitat Seckl J, Dunger D (1989) Postoperative diabetes insipidus. BMJ 298:2–3CrossRef Seckl J, Dunger D (1989) Postoperative diabetes insipidus. BMJ 298:2–3CrossRef
4.
Zurück zum Zitat Makaryus AN, McFarlane SI (2006) Diabetes insipidus: diagnosis and treatment of a complex disease. Cleve Clin J Med 73:65–71CrossRef Makaryus AN, McFarlane SI (2006) Diabetes insipidus: diagnosis and treatment of a complex disease. Cleve Clin J Med 73:65–71CrossRef
5.
Zurück zum Zitat Sheehan JM, Sheehan JP, Douds GL, Page RB (2006) DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) 148:287–291CrossRef Sheehan JM, Sheehan JP, Douds GL, Page RB (2006) DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) 148:287–291CrossRef
6.
Zurück zum Zitat Nayak P, Montaser AS, Hu J, Prevedello DM, Kirschner LS, Ghalib L (2018) Predictors of postoperative diabetes insipidus following endoscopic resection of pituitary adenomas. J Endocr Soc 2:1010–1019CrossRef Nayak P, Montaser AS, Hu J, Prevedello DM, Kirschner LS, Ghalib L (2018) Predictors of postoperative diabetes insipidus following endoscopic resection of pituitary adenomas. J Endocr Soc 2:1010–1019CrossRef
7.
Zurück zum Zitat Schreckinger M, Walker B, Knepper J, Hornyak M, Hong D, Kim JM, Folbe A, Guthikonda M, Mittal S, Szerlip NJ (2013) Post-operative diabetes insipidus after endoscopic transsphenoidal surgery. Pituitary 16:445–451CrossRef Schreckinger M, Walker B, Knepper J, Hornyak M, Hong D, Kim JM, Folbe A, Guthikonda M, Mittal S, Szerlip NJ (2013) Post-operative diabetes insipidus after endoscopic transsphenoidal surgery. Pituitary 16:445–451CrossRef
8.
Zurück zum Zitat Sigounas DG, Sharpless JL, Cheng DM, Johnson TG, Senior BA, Ewend MG (2008) Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery. Neurosurgery 62:71–78CrossRef Sigounas DG, Sharpless JL, Cheng DM, Johnson TG, Senior BA, Ewend MG (2008) Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery. Neurosurgery 62:71–78CrossRef
9.
Zurück zum Zitat Ajlan AM, Abdulqader SB, Achrol AS, Aljamaan Y, Feroze AH, Katznelson L, Harsh GR (2018) Diabetes insipidus following endoscopic transsphenoidal surgery for pituitary adenoma. J Neurol Surg B Skull Base 79:117–122CrossRef Ajlan AM, Abdulqader SB, Achrol AS, Aljamaan Y, Feroze AH, Katznelson L, Harsh GR (2018) Diabetes insipidus following endoscopic transsphenoidal surgery for pituitary adenoma. J Neurol Surg B Skull Base 79:117–122CrossRef
10.
Zurück zum Zitat Chuang CC, Lin SY, Pai PC, Yan JL, Toh CH, Lee ST, Wei KC, Liu ZH, Chen CM, Wang YC, Lee CC (2017) Different volumetric measurement methods for pituitary adenomas and their crucial clinical significance. Sci Rep 7:40792CrossRef Chuang CC, Lin SY, Pai PC, Yan JL, Toh CH, Lee ST, Wei KC, Liu ZH, Chen CM, Wang YC, Lee CC (2017) Different volumetric measurement methods for pituitary adenomas and their crucial clinical significance. Sci Rep 7:40792CrossRef
11.
Zurück zum Zitat Kim JH, Lee JH, Lee JH, Hong AR, Kim YJ, Kim YH (2018) Endoscopic transsphenoidal surgery outcomes in 331 nonfunctioning pituitary adenoma cases after a single surgeon learning curve. World Neurosurg 109:e409–e416CrossRef Kim JH, Lee JH, Lee JH, Hong AR, Kim YJ, Kim YH (2018) Endoscopic transsphenoidal surgery outcomes in 331 nonfunctioning pituitary adenoma cases after a single surgeon learning curve. World Neurosurg 109:e409–e416CrossRef
12.
Zurück zum Zitat Yoon HK, Lee HC, Kim YH, Lim YJ, Park HP (2019) Predictive factors for delayed hyponatremia after endoscopic transsphenoidal surgery in patients with nonfunctioning pituitary tumors: a retrospective observational study. World Neurosurg 122:e1457–e1464CrossRef Yoon HK, Lee HC, Kim YH, Lim YJ, Park HP (2019) Predictive factors for delayed hyponatremia after endoscopic transsphenoidal surgery in patients with nonfunctioning pituitary tumors: a retrospective observational study. World Neurosurg 122:e1457–e1464CrossRef
14.
Zurück zum Zitat Senior BA, Ebert CS, Bednarski KK, Bassim MK, Younes M, Sigounas D, Ewend MG (2008) Minimally invasive pituitary surgery. Laryngoscope 118:1842–1855CrossRef Senior BA, Ebert CS, Bednarski KK, Bassim MK, Younes M, Sigounas D, Ewend MG (2008) Minimally invasive pituitary surgery. Laryngoscope 118:1842–1855CrossRef
15.
Zurück zum Zitat Gubbi S, Hannah-Shmouni F, Koch CA, Verbalis JG (2000) Diagnostic Testing for Diabetes Insipidus. Endotext, South Dartmouth Gubbi S, Hannah-Shmouni F, Koch CA, Verbalis JG (2000) Diagnostic Testing for Diabetes Insipidus. Endotext, South Dartmouth
16.
Zurück zum Zitat Arieff AI, Guisado R (1976) Effects on the central nervous system of hypernatremic and hyponatremic states. Kidney Int 10:104–116CrossRef Arieff AI, Guisado R (1976) Effects on the central nervous system of hypernatremic and hyponatremic states. Kidney Int 10:104–116CrossRef
17.
Zurück zum Zitat Dumont AS, Nemergut EC 2nd, Jane JA Jr, Laws ER Jr (2005) Postoperative care following pituitary surgery. J Intensive Care Med 20:127–140CrossRef Dumont AS, Nemergut EC 2nd, Jane JA Jr, Laws ER Jr (2005) Postoperative care following pituitary surgery. J Intensive Care Med 20:127–140CrossRef
18.
Zurück zum Zitat Seckl JR, Dunger DB, Lightman SL (1987) Neurohypophyseal peptide function during early postoperative diabetes insipidus. Brain 110:737–746CrossRef Seckl JR, Dunger DB, Lightman SL (1987) Neurohypophyseal peptide function during early postoperative diabetes insipidus. Brain 110:737–746CrossRef
19.
Zurück zum Zitat Patel PN, Stafford AM, Patrinely JR, Smith DK, Turner JH, Russell PT, Weaver KD, Chambless LB, Chandra RK (2018) Risk factors for intraoperative and postoperative cerebrospinal fluid leaks in endoscopic transsphenoidal sellar surgery. Otolaryngol Head Neck Surg 158:952–960CrossRef Patel PN, Stafford AM, Patrinely JR, Smith DK, Turner JH, Russell PT, Weaver KD, Chambless LB, Chandra RK (2018) Risk factors for intraoperative and postoperative cerebrospinal fluid leaks in endoscopic transsphenoidal sellar surgery. Otolaryngol Head Neck Surg 158:952–960CrossRef
20.
Zurück zum Zitat Rose SR, Horne VE, Bingham N, Jenkins T, Black J, Inge T (2018) Hypothalamic obesity: 4 years of the international registry of hypothalamic obesity disorders. Obesity (Silver Spring) 26:1727–1732CrossRef Rose SR, Horne VE, Bingham N, Jenkins T, Black J, Inge T (2018) Hypothalamic obesity: 4 years of the international registry of hypothalamic obesity disorders. Obesity (Silver Spring) 26:1727–1732CrossRef
21.
Zurück zum Zitat Steele CA, Cuthbertson DJ, MacFarlane IA, Javadpour M, Das KS, Gilkes C, Wilding JP, Daousi C (2013) Hypothalamic obesity: prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic. Eur J Endocrinol 168:501–507CrossRef Steele CA, Cuthbertson DJ, MacFarlane IA, Javadpour M, Das KS, Gilkes C, Wilding JP, Daousi C (2013) Hypothalamic obesity: prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic. Eur J Endocrinol 168:501–507CrossRef
22.
Zurück zum Zitat Bokhari AR, Davies MA, Diamond T (2013) Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve. Br J Neurosurg 27:44–49CrossRef Bokhari AR, Davies MA, Diamond T (2013) Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve. Br J Neurosurg 27:44–49CrossRef
23.
Zurück zum Zitat Chi F, Wang Y, Lin Y, Ge J, Qiu Y, Guo L (2013) A learning curve of endoscopic transsphenoidal surgery for pituitary adenoma. J Craniofac Surg 24:2064–2067CrossRef Chi F, Wang Y, Lin Y, Ge J, Qiu Y, Guo L (2013) A learning curve of endoscopic transsphenoidal surgery for pituitary adenoma. J Craniofac Surg 24:2064–2067CrossRef
24.
Zurück zum Zitat Thawani JP, Ramayya AG, Pisapia JM, Abdullah KG, Lee JY, Grady MS (2017) Operative strategies to minimize complications following resection of pituitary macroadenomas. J Neurol Surg B Skull Base 78:184–190PubMed Thawani JP, Ramayya AG, Pisapia JM, Abdullah KG, Lee JY, Grady MS (2017) Operative strategies to minimize complications following resection of pituitary macroadenomas. J Neurol Surg B Skull Base 78:184–190PubMed
25.
Zurück zum Zitat Zhan R, Ma Z, Wang D, Li X (2015) Pure endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary adenomas in the elderly: surgical outcomes and complications in 158 patients. World Neurosurg 84:1572–1578CrossRef Zhan R, Ma Z, Wang D, Li X (2015) Pure endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary adenomas in the elderly: surgical outcomes and complications in 158 patients. World Neurosurg 84:1572–1578CrossRef
26.
Zurück zum Zitat Vimawala S, Chitguppi C, Reilly E, Fastenberg JH, Garzon-Muvdi T, Farrell C, Rabinowitz MR, Rosen MR, Evans J, Nyquist GG (2020) Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma. Int Forum Allergy Rhinol 10:785–790CrossRef Vimawala S, Chitguppi C, Reilly E, Fastenberg JH, Garzon-Muvdi T, Farrell C, Rabinowitz MR, Rosen MR, Evans J, Nyquist GG (2020) Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma. Int Forum Allergy Rhinol 10:785–790CrossRef
Metadaten
Titel
Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma
verfasst von
Hyongmin Oh
Hyeon Cheun
Yoon Jung Kim
Hyun-Kyu Yoon
Ho Kang
Hyung-Chul Lee
Hee-Pyoung Park
Jung Hee Kim
Yong Hwy Kim
Publikationsdatum
16.11.2020
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2021
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-020-01108-1

Weitere Artikel der Ausgabe 3/2021

Pituitary 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.